Secretary Azar Visits Peruvian Hospital and Meets with Venezuelan Healthcare ProfessionalsMay 2, 2019
Secretary Azar Attends Health Ministerial Meeting in Lima, Peru in Response to Health Impacts of Forced Displacement in the RegionMay 1, 2019
Statement from Acting FDA Commissioner Ned Sharpless, M.D., and Deputy Commissioner Frank Yiannas on steps to usher the U.S. into a new era of smarter food safetyMay 1, 2019
FDA permits sale of IQOS Tobacco Heating System through premarket tobacco product application pathwayMay 1, 2019
FDA requires stronger warnings about rare but serious incidents related to certain prescription insomnia medicinesMay 1, 2019
HHS Officials Highlight Safety and Effectiveness of Vaccines and National Infant Immunization WeekApril 29, 2019
HHS and the American Society of Nephrology Award KidneyX Redesign Dialysis Phase 1 WinnersApril 29, 2019
Inspired Organics Issues Voluntary Recall of Organic Nut & Seed Butters Due to Potential Health RiskApril 27, 2019
The J.M. Smucker Company Issues Voluntary Recall of Specific Lots of 9Lives® Protein Plus® Wet, Canned Cat Food Due to Low Levels of Thiamine (Vitamin B1)April 27, 2019
Danone North America Issues Allergy Alert and Recall for Light & Fit Greek Crunch S’mores FlavorApril 27, 2019
Inspired Organics Issues Voluntary Recall of Organic Sunflower Butter Due to Potential Health RiskApril 27, 2019
Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USPApril 27, 2019
Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical SupplyApril 26, 2019
FDA launches public education campaign to encourage safe removal of unused opioid pain medicines from homesApril 25, 2019
Legacy Pharmaceutical Packaging, LLC Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity Found in the Active Pharmaceutical Ingredient (API)April 25, 2019
